Effect of Aspirin Dose on Gastrointestinal Permeability

Abstract

The primary purpose of this study was to determine the aspirin dose that increases gastrointestinal (GI) permeability. A pilot study was also conducted to determine whether the menstrual cycle affects GI permeability. Both portions of the study involved 4 experimental conditions. For the aspirin portion, 8 subjects ingested 0 mg, 325 mg, 650 mg, or 975 mg of aspirin the night before and the morning of an experiment. For the menstrual cycle pilot study, 5 female subjects with regular menstrual cycles were tested for GI permeability on the same day each week for 4 weeks. GI permeability was assessed by the urinary excretion of ingested probes. Sucrose (5 g) was used to determine gastroduodenal permeability. Lactulose (5 g) and rhamnose (2 g) were used to assess small intestinal permeability via the lactulose-to-rhamnose urinary excretion ratio (L/R). The data indicated that the menstrual cycle had no effect on GI permeability. In contrast, gastroduodenal permeability was significantly (P <0.008) increased following a dose of 650 mg aspirin and small intestinal permeability (L/R) was significantly (P <0.008) increased following a dose of 975 mg aspirin. These results suggest healthy individuals should be cautious even with acute aspirin use as it may result in GI barrier dysfunction.

Key words

gut - menstrual cycle - athletes

• References

• 1 Bjarnason I, MacPherson A, Hollander D. Intestinal permeability: an overview. Gastroenterology 1995; 108: 1566-1581
• 2 Bjarnason I, Williams P, Smethurst P, Peters TJ, Levi AJ. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut 1986; 27: 1292-1297
• 3 Bjarnason I, Zanelli G, Prouse P, Williams P, Gumpel MJ, Levi AJ. Effect of non-steroidal anti-inflammatory drugs on the human small intestine. Drugs 1986; 32 (Suppl. 01) 35-41
• 4 Bovo P, Paola Brunori M, Di Francesco V, Frulloni L, Montesi G, Cavallini G. The mentrual cycle has no effect on gastrointestinal transit time. Evaluation by means of the lactulose H2 breath test. Ital J Gastroenterol 1992; 24: 449-451
• 5 Brock-Utne J, Gaffin S, Wells M, Gathiram P, Sohar E, James M, Morrell D, Norman R. Endotoxemia in exhausted runners after a long-distance race. S Afr Med J 1988; 73: 533-536
• 6 Fred HL. The 100-mile run: preparation, performance, and recovery: A case report. Am J Sports Med 1981; 9: 258-261
• 7 Garnett WR. GI effects of OTC analgesics: implications for product selection. J Am Pharm Assoc 1996; NS36: 565-572
• 8 Gisolfi CV. Is the GI system built for exercise?. News Physiol Sci 2000; 15: 114-119
• 9 Gisolfi CV, Mora F. The Hot Brain. Cambridge: The MIT Press; 2000. 158.
• 10 Harriss DJ, Atkinson G. Update – Ethical standards in sport and exercise science research. Int J Sports Med 2011; 32: 819-821
• 11 Jackson LM, Hawkey CJ. NSAIDs and the GI tract-potential hazards and benefits. Apoptosis 1999; 4: 397-402
• 12 Jeukendrup AE, Vet-Joop K, Sturk A, Stegen JH, Senden J, Saris WH, Wagenmakers AJ. Relationship between gastro-intestinal complaints and endotoxemia, cytokine release and the acute-phase reaction during and after a long-distance triathlon in highly trained men. Clin Sci (Lond) 2000; 98: 47-55
• 13 Lambert GP. Intestinal barrier dysfunction, endotoxemia and gastrointestinal symptoms: The ‘canary in the coal mine’ during exercise-heat stress?. In: Marino FE. (ed.) Medicine and Sport Science. Vol. 53. Thermoregulation and Human Performance: Physiological and Biological Aspects Basel: Karger; 2008: 61-73
• 14 Lambert GP. Role of gastrointestinal permeability in exertional heatstroke. Exerc Sport Sci Rev 2004; 32: 185-190
• 15 Lambert GP. Stress-induced gastrointestinal barrier dysfunction and its inflammatory effects. J Anim Sci 2009; 87: E101-E108
• 16 Lambert GP, Boylan MW, Laventure J-P, Bull AJ, Lanspa SJ. Effect of aspirin and ibuprofen on GI permeability during exercise. Int J Sports Med 2007; 28: 722-726
• 17 Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993; 104: 1619-1626
• 18 Mones J, Carrio I, Calabuig R, Estorch M, Sainz S, Berna L, Vilardell F. Influence of the menstrual cycle and of menopause on the gastric emptying rate of solids in female volunteers. Eur J Nucl Med 1993; 20: 600-602
• 19 Payan DG, Shearn MA. Nonsteroidal anti-inflammatory drugs; Nonopioid analgesics; Drugs used in gout. In: Katzung BG. ed. Basic and Clinical Pharmacology. 4^th edition Norwalk: Appleton & Lange; 1989: 431-450
• 20 Ryan AJ, Chang R-T, Gisolfi CV. Gastrointestinal permeability following aspirin intake and prolonged running. Med Sci Sports Exerc 1996; 28: 698-705
• 21 Sigthorsson G, Tibble J, Hayllar J, Menzies I, Macpherson A, Moots R, Scott D, Gumpel MJ, Bjarnason I. Intestinal permeability and inflammation in patients on NSAIDS. Gut 1998; 43: 506-511
• 22 Somasundaram S, Hayllar H, Rafi S, Wrigglesworth JM, Macpherson AJS, Bjarnson I. The biochemical basis of non-steroidal anti-inflammatory drug-induced damage to the gastrointestinal tract: a review and a hypothesis. Scand J Gastroent 1995; 30: 289-299
• 23 Somasundaram S, Sigthorsson G, Simpson RJ, Watts J, Jacob M, Tavares IA, Rafi S, Roseth A, Foster R, Price AB, Wrigglesworth JM, Bjarnason I. Uncoupling of intestinal mitochondiral oxidative phosphorylation and inhibition of cyclooxygenase are requried for the development of NSAID-enteropathy in the rat. Aliment Pharmacol Ther 2000; 15: 639-650
• 24 Tomlinson J, Blikslager A. Role of nonsteroidal anti-inflammatory drugs in gastrointestinal tract injury and repair. J Am Vet Med Assoc 2003; 222: 946-951